Currently out of the existing stock ratings of Robert Marcus, 8 are a HOLD (80%), 1 are a SELL (10%), 1 are a BUY (10%).

Robert Marcus

Work Performance Price Targets & Ratings Chart

Analyst Robert Marcus, currently employed at JPMORGAN, carries an average stock price target met ratio of 85.03% that have a potential upside of 12.41% achieved within 119 days.

Robert Marcus’s has documented 52 price targets and ratings displayed on 12 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on PODD, Insulet at 07-May-2026.

Wall Street Analyst Robert Marcus

Analyst best performing recommendations are on NVRO (NEVRO CORP).
The best stock recommendation documented was for NVRO (NEVRO CORP) at 12/1/2014. The price target of $34 was fulfilled within 2 days with a profit of $5.15 (17.85%) receiving and performance score of 89.25.

Average potential price target upside

of $30.86 (15.4%) on PEN (PENUMBRA).
of $29.2 (16.82%) on PODD (INSULET).
of $16.52 (15.06%) on NVRO (NEVRO CORP).

PEN Penumbra BDX Becton Dickinson and Company DXCM DexCom GKOS Glaukos Corp IART Integra LifeSciences Holdings INGN Inogen MDT Medtronic PLC NVRO Nevro Corp PODD Insulet TMDX TransMedics Group XENT Intersect ENT ZBH Zimmer Biomet Holdings

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Vijay Kumar (EVERCORE)